Literature DB >> 9325243

Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells.

M Díaz-Guerra1, C Rivas, M Esteban.   

Abstract

The interferon (IFN)-induced enzyme RNase L produced by a recombinant vaccinia virus (VV) causes death of mammalian cells with morphological and biochemical characteristics of apoptosis. Coexpression of 2-5A-synthetase enhances apoptosis induced by RNase L Activation of endogenous RNase L by infection with a VV ts mutant (ts22) or with wild-type virus in the presence of the antipoxvirus drug isatin-beta-thiosemicarbazone, a treatment known to significantly increase the amount of double-stranded RNA late during infection, also causes pronounced apoptosis of infected cells. The effects observed with recombinant virus-derived RNase L or with the endogenous enzyme are specific, since apoptosis also occurs in cells derived from mice lacking the IFN-induced protein kinase (PKR). The apoptosis antagonist Bcl-2 prevents induction of cell death by RNase L activation. Apoptosis of mammalian cells by RNase L activation could be a mechanism mediating anticellular actions of IFN.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325243     DOI: 10.1006/viro.1997.8719

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

Review 1.  Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor.

Authors:  R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB.

Authors:  J Gil; J Alcamí; M Esteban
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Toll-like receptor ligands directly promote activated CD4+ T cell survival.

Authors:  Andrew E Gelman; Jidong Zhang; Yongwon Choi; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

4.  Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.

Authors:  Zeng B Zhu; Angel A Rivera; Sharmila K Makhija; Baogen Lu; Minghui Wang; Miiru Izumi; Robert J Cerfolio; Mariam A Stoff-Khalili; Fen Zhou; Koichi Takayama; Gene P Siegal; David T Curiel
Journal:  Lung Cancer       Date:  2006-11-17       Impact factor: 5.705

Review 5.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

6.  Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA.

Authors:  Kerstin Brack; Iris Berk; Thomas Magulski; Jörg Lederer; Andreas Dotzauer; Angelika Vallbracht
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.

Authors:  W W Leitner; H Ying; D A Driver; T W Dubensky; N P Restifo
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

8.  Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.

Authors:  Trung P Huynh; James K Jancovich; Latha Tripuraneni; Michael C Heck; Jeffrey O Langland; Bertram L Jacobs
Journal:  Virology       Date:  2017-09-14       Impact factor: 3.616

9.  Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Authors:  Elena Domingo-Gil; Eva Pérez-Jiménez; Iván Ventoso; José L Nájera; Mariano Esteban
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  The mitochondrial antiviral signaling protein, MAVS, is cleaved during apoptosis.

Authors:  Iain Scott; Kristi L Norris
Journal:  Biochem Biophys Res Commun       Date:  2008-08-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.